2,2-Methylenebis(4-Ethyl-6-Tert-Butylphenol)
CAS NO.: 88-24-4
Purity :98%
Compound | GLYX-13 trifluoroacetate | ||||
---|---|---|---|---|---|
CAS No. | 117928-94-6 | Catalog No. | 741032 | Brand | |
Purity | 98 | Packing | 1g | Grade | |
Lead Time | 3Day (s) | Origin | Loading Port |
Rapatinib is an NMDAR (N-methyl-D-aspartate receptor) regulator with partial agonist properties. Rapatinel is a new antidepressant, which has been approved as an adjuvant drug for the treatment of refractory major depression. It is a centrally active, intravenous (non oral) chemicalbook amidated tetrapeptide that acts as a selective and weak local agonist (mixed antagonist / agonist) at the glycine site of the NMDA receptor complex (emax25%). The drug is a rapid and long-acting antidepressant. At the same time, it has the ability to inhibit and enhance NMDA receptor-mediated signal transduction. It is a powerful intellectual enhancer.
CAS No : 64806-05-9
CAS No : 67869-62-9
CAS No : 117928-94-6
CAS No : 147859-80-1
CAS No : 137255-40-4
2-[4,8,11-tris(2-amino-2-oxoethyl)-1,4,8,11-tetrazacyclotetradec-1-yl]acetamide
CAS No : 345612-63-7
(3,4,5-triacetyloxy-6-diethylphosphanylsulfanyloxan-2-yl)methyl acetate
CAS No : 55263-69-9
CAS No : 13284-64-5